Eleven Program (Eleven Biotherapeutics/ThromboGenics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEleven Program (Eleven Biotherapeutics/ThromboGenics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic eye disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxurion Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSesen Bio IncOxurion Nv
Active IndicationsN/A
Inactive IndicationsDiabetic eye disease

Other Information

ATC CodeN/A
Related LinksN/A